Stories about research and scientific development at Mount Sinai
A Thank You to Clinical Trial Participants
Physician-scientists from Mount Sinai Beth Israel and The Michael J. Fox Foundation highlighted new treatments and research in Parkinson’s disease during a “Thankfest” symposium and lunch in October. The event was held to recognize the valuable contributions of 60...
First Place for Neurosurgery
The Department of Neurosurgery at the Icahn School of Medicine at Mount Sinai received the first place award for most accepted abstracts by residents at the 2019 Congress of Neurological Surgeons (CNS) Annual Meeting, which took place in October in San Francisco. The...
Novel Cancer Immunotherapies Show Promise
Researchers at the Icahn School of Medicine at Mount Sinai are pioneering two novel approaches to cancer immunotherapy that are promising for patients with non-Hodgkin lymphoma and other solid tumors, which have been stubbornly resistant to therapies such...
Gene Variant Is Strongly Linked to Heart Failure
A genetic variation that is prevalent in people of African or Hispanic/Latino ancestry was significantly associated with heart failure in a study by researchers at the Icahn School of Medicine at Mount Sinai and the Perelman School of Medicine...
Mount Sinai Leads in Noninvasive Thyroid Treatment
Mount Sinai has become one of the few health systems in the nation to offer a new minimally invasive procedure to treat noncancerous thyroid nodules. The procedure, called radiofrequency ablation (RFA), offers eligible patients a quicker recovery and minimal scarring,...
Universal Flu Vaccine Moves Closer to Fruition
The quest to develop a universal influenza vaccine that would be administered only once or twice in an individual’s lifetime and cover every strain of the virus moved closer to becoming a reality in October, when researchers at the Icahn School of Medicine at Mount...
SinaInnovations 2019: A Close-up Look at Artificial Intelligence
What is the role of artificial intelligence (AI) in medicine, and how is it changing the practice of health care as we know it? That was the subject of the eighth annual SinaInnovations Conference, held Tuesday, October 15, and Wednesday, October 16, in Stern...
Rachel Yehuda, PhD, Pioneering Researcher, Is Elected to the National Academy of Medicine
Rachel Yehuda, PhD, a world-renowned researcher whose pioneering discoveries have revolutionized the study and treatment of post-traumatic stress disorder (PTSD), has been elected to the National Academy of Medicine. Dr. Yehuda is Professor and Vice Chair for Veterans...
2019 Mount Sinai Health Hackathon Winners
One hundred eighty medical and graduate students, and others, formed 19 teams to participate in the fourth annual Mount Sinai Health Hackathon in October. The 48-hour competition, held over the weekend leading up to the SinaInnovations Conference, challenged the...